Recent Articles

• Evaxion Biotech Modifies ADS Ratio Change Timeline
• RhyGaze Secures USD 86 Million to Advance Vision Restoration Therapy
• Westwood ETFs Announce Impressive Monthly Distributions
• Galectin Therapeutics Unveils Groundbreaking Findings at MASH-TAG
• Leonardo DRS Announces Earnings Call for Q4 2024 Results
• Tanger Announces Key Earnings Release for 2024 Performance
• Understanding Michelin's Capital and Voting Rights Breakdown
• Character Biosciences Partners with Bausch + Lomb for AMD Treatment
• Park Aerospace's Upcoming Earnings Release: What to Expect
• VIPR Solutions Expands with New Clients and Innovative Technology
• Diamond Lake Minerals Leads Healthcare Innovation with Acquisition
• Verismo Therapeutics Begins Clinical Trial with SynKIR-310
• Savers Value Village, Inc. Reveals Sales Growth and Conference Plans
• NextCure Doses First Patient in Groundbreaking Cancer Study
• Bank of Montreal Launches Automatic Securities Purchase Initiative
• Revvity Launches Innovative FDA-Cleared Testosterone Test
• BTCS Unveils New Staker Protection Plan for Ethereum Validators
• CapsoVision's CapsoCam Plus® Revolutionizes Pediatric Endoscopy
• ESA Leads Community Solar Initiatives with 2024 Achievements
• OrthoPediatrics Expands Its Specialty Bracing Division for Kids
• Investigation into Hasbro Inc. (HAS): Your Rights Explained
• Regal Rexnord Announces Conference Call for Q4 Earnings Review
• PAR Technology Corporation Engages Investors at Key Conference
• High Roller Technologies Expands Leadership with Kristofer Muscat
• Powerfleet to Highlight Innovation at the Upcoming Conference
• Lazard's Upcoming Financial Results: What to Expect This Year
• Veritex Holdings Plans Fourth Quarter Earnings Announcement
• Wealth Enhancement Expands Reach with Strategic Acquisition
• Octopus AIM VCT PLC Announces New Ordinary Shares Issuance
• Serna Bio Welcomes Experts to Enhance Drug Discovery Approaches
• Galectin Therapeutics to Showcase Innovative Liver Therapy Insights
• Kyverna Therapeutics Faces Class Action: Investors Urged to Act
• Key Milestones for Intensity Therapeutics' INT230-6 Drug Candidate
• BullFrog AI Showcases Innovative AI Solutions at Upcoming Event
• Kardigan Sets New Standards in Cardiovascular Drug Development
• Insmed's Promising Updates on ARIKAYCE and Brensocatib Growth
• WisdomTree December Metrics Showcase Growth Amid Challenges
• Totus Medicines Advances TOS-358 Development with New Leadership
• Innovative Cancer Vaccine Development: Diakonos at Biotech Event
• Diamond Lake Minerals Expands with Non-Invasive Clinics Acquisition
• Rallybio's Innovations Showcased and Future Goals Set
• Tyra Biosciences Advances Cancer Treatment with IND Approval for TYRA-300
• Microvast's New Battery Tech Boosts Stock Performance Significantly
• Dr. Alastair Leighton Joins Chemify as COO to Drive Innovation
• Bank of America’s Consumer Investments Hits $500 Billion Milestone
• Spectral Capital Appoints Aaron Christensen as New CRO
• Xylo's Transformation: New Leadership and Innovative Advances
• Harbour BioMed Partners with Windward Bio for Immunological Antibody
• Spring Break 2025: Rising Costs and Changing Trends Explained
• XPPen Introduces the Artist Pro 22 (Gen 2): Redefining Digital Art